ADVANCED HEALTH INTELLIGENCE LTD

Research

Advanced Health Intelligence (AHI, formerly Advanced Human Imaging) is an Australian digital health company. It sells patented, camera-based health assessment tools: FaceScan (vitals estimated from a phone or web camera), BodyScan (body composition) and a Digital Health Assessment (cardiovascular, metabolic and mental health risk). Its use cases are insurer risk stratification and underwriting and engaging remote populations. It acquired Wellteq in 2022, then shut down that wellness platform and terminated all its customer agreements (H1 FY24 report). It was removed from the ASX in October 2025 for failing to lodge periodic reports. I found no public confirmation of the 2026 administration or the DOCA. Whether the business is still operating is unclear.

Human hours a week after AI	10-20 hours a week. Compliance, model upkeep and enterprise relationships would remain, and sales effort is on top of that.
AI and tools can do	Hosting and updates, backups, monitoring, billing, first-line support and website changes could all be automated. Routine SDK bug fixes could use AI coding tools.
Operating changes	Assumed changes: stop bespoke pilots and demos for enterprises, move all support to email and docs, and raise prices. The timing depends on the contract terms, which are unknown. Costs could include losing insurer or enterprise clients who expect account management. Any contracts may not survive the administration or the DOCA.
Stays human	Handling regulated health and biometric data, privacy compliance, managing model accuracy and any clinical claims, enterprise sales and integration calls, handling incidents, and maintaining patents.
Why valuable	It has patented camera-based health-estimation technology and a working product set, and a distressed seller may sell it cheaply. The buyer could use it as a technology asset or white-label component.
Fit	Poor. The buyer wants sticky recurring B2B software that one part-time person can run. This is regulated, enterprise-sold, AI-model-heavy health technology with no evidence of recurring customers.

Next step

Check ASIC and the Published Notices site, and the administrator's (Carrello's) firm page, for the DOCA terms and creditor reports. Then ask the administrator, as a human, whether any IP is being sold and which creditors hold security over it.

Risks

The IP may be encumbered by secured creditors or controlled under the DOCA, so it may not be for sale
Health and biometric data regulation and liability
The company was delisted for missing reports, and Wellteq customers were terminated
Machine-learning models and training data may not be included in a sale
Patent maintenance fees and the cost of keeping the patents alive
The business may no longer be operating

Unknowns

Whether the business is still trading
Customer count, contracts and revenue
What the DOCA covers and whether any assets are being sold
Which assets secured creditors hold
Source code, model and data ownership
Real operational state and the team that remains

Researched 16 Oct 2026 00:30 · US$0.08

Score

Dimension	Rating	Evidence	Why
recurring_customers	?	unknown	No customers, revenue or pricing are public. The earlier Wellteq customers were terminated.
software_ownership	4/5	verified	AHI describes its platforms as its own proprietary and patented technology. Whether the IP can be transferred is unknown, and secured creditors have claims over the assets.
customer_stickiness	2/5	unknown	This is an SDK/API-style assessment tool that insurers could swap out. Integration effort gives some stickiness, but no contract evidence was found.
low_operational_complexity	1/5	inferred	The product handles health data (regulated), uses computer-vision models that need validation, and sells to enterprise insurers through demos and meetings. Patent and clinical-claims upkeep adds to this. A part-time solo operator would struggle.
technical_recoverability	2/5	unknown	The stack is unknown. Custom computer-vision models and any training data would be hard for one person to maintain and retrain. Source code and model access are not confirmed.
acquisition_accessibility	2/5	verified	A DOCA is a deed with creditors rather than a liquidator sale, so assets may not be available this way. The administrator is named (Carrello), but no sale notice was found.
capital_fit	2/5	inferred	Patents and models from a company that raised many millions probably cost more than A$60k. A distressed sale might fit, but there is no price evidence.

Evidence

verified	AHI markets its own FaceScan product delivered via web or smartphone “Health vital estimates delivered via web or smartphone using camera-sensor inputs in around two minutes.”	ahi.tech
inferred	Patents are cited across several regions. This came from the page summary, not an exact quote, so it is inferred.	ahi.tech
unknown	The website names no customers or pricing. Its only calls to action are demo and meeting bookings.	ahi.tech
inferred	The Wellteq platform was shut down and all of its customer agreements were terminated, which means the company lost customers.	sec.gov
verified	ASX removed AHI from the Official List effective 1 October 2025 for failing to lodge a periodic report for over a year. “AHI) is set to be removed from the ASX Official List due to its failure to lodge a required periodic report for over a year.”	tipranks.com
unknown	A search found no sale notice, administrator page or DOCA details for AHI.
inferred	A bridging loan was secured over company assets, ranking behind two existing secured creditors. This means secured creditors may have first claim on the IP.	announcements.asx.com.au

Company

Practitioners	CARRELLO, GIOVANNI MAURIZIO
Industry	Other Information Services · Western Australia
Pre-filter	industry industry: Other Information Services

History

2026-04-13 Voluntary administration (CARRELLO, GIOVANNI MAURIZIO)
2026-07-13 Deed of company arrangement (CARRELLO, GIOVANNI MAURIZIO)

ASIC notices

none read

Screen

The pages describe AHI's own patented, proprietary platforms (Digital Health Assessment, FaceScan, BodyScan) delivered to users via web or smartphone, and a Digital Health Check solution listed as a marketplace offering.

Digital Health Assessment “Comprehensive health risk assessments for actionable insights on cardiovascular, metabolic and mental health risks.”

FaceScan “FaceScan Health vital estimates delivered via web or smartphone using camera-sensor inputs in around two minutes.”

BodyScan “A quick and simple way to self-assess body composition and dimension, plus associated health risks, in comfort and privacy.”

Digital Health Check (DHC) “listed its Digital Health Check (DHC) solution as an offering in the Azure Marketplace”

customers: Unisure will deploy AHI's Digital Health Assessment and Digital Health Check in its digital underwriting and consumer rewards capability. “Unisure will deploy a digital underwriting and consumer rewards capability using AHI’s Digital Health Assessment and Digital Health Check.”

customers: AHI integrated its Digital Health Assessment into VITALL's SaaS platform VITALLEngage for first customer rollout. “completing integration of its Digital Health Assessment (DHA, formerly known as the Biometric Health Assessment) within VITALL's Software as a Service (SaaS) delivery platform, VITALLEngage.”

revenue_model: Digital Health Check is offered for sale as a listing in the Azure Marketplace. “listed its Digital Health Check (DHC) solution as an offering in the Azure Marketplace”

technology: Platforms are patented and proprietary and use camera sensor inputs to produce risk estimates. “AHI offers patented and proprietary platforms that leverage camera sensor inputs to return risk estimates for a range of conditions”

status: The most recent news item (February 2026) reports new marketplace registration and listing, indicating the business was active. “AHI has completed registration for the Microsoft ISV Success program as an AI Cloud Partner”